Skip to content

Electrocardiogram (ECG) Validation Study

SANSA Electrocardiogram (ECG) Validation Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06414447
Enrollment
15
Registered
2024-05-16
Start date
2024-05-31
Completion date
2024-07-31
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrythmia

Brief summary

Comparison of diagnostic Electrocardiogram (ECG) signals

Interventions

DIAGNOSTIC_TESTHuxley Medical

diagnostic

Sponsors

Huxley Medical, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age of older * Able to read, understand, and sign informed consent documentation willing to wear the Sansa device and 3-lead or 5-lead Holter monitor simultaneously for 24- hours * In the opinion of the investigator, subject is willing to comply with the protocol

Exclusion criteria

* Noted deformities of the chest (e.g., pronounced scarring, pectus carinatum) that would Interfere with sensor placement * broken or injured skin that would interfere with sensor placement, are known to experience adverse reactions to medical-grade adhesive * pacemaker dependent * females who are pregnant (self-reported)

Design outcomes

Primary

MeasureTime frame
Comparison of the diagnostic Electrocardiogram (ECG) signal quality of the P, QRS and T wave deflections of the Sansa device to a reference standard Holter monitor3 months

Contacts

Primary ContactJill Fricke
jfricke@huxleymed.com949-310-4697

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026